Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.51.3
PrivacidadTérminosCookiesAviso Legal
● Connected
CBIH US Equity
Cannabis Bioscience International Holdings, Inc.
0.00USD
Healthcare
Drug Manufacturers - Specialty & Generic
96)Comparar97)Tesis →
Market Cap
$2M
Shares Outstanding
11.6B
Revenue (TTM)
$123,627
Net Income (TTM)
−$515,288
— Annual —FY2025
Revenue
$303,022
Gross Margin
86.8%
Operating Margin
-139.1%
Net Margin
-181.1%
ROCE
46.1%
Current Ratio
0.03
D/E Ratio
-0.25
Book Value / Share
-0
CBIH US Equity
0.00USD
Tesis →

Cannabis Bioscience International Holdings, Inc. (CBIH): análisis fundamental y valoración

Cannabis Bioscience International Holdings, Inc. cotiza a 0.00 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaOTCPaísUnited StatesEmpleados2Beta0.94

Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education …

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
8.6×
P/Sales
7.7×
P/Book
—
Rentabilidad (Último Anual)
Gross Margin
86.8%
Operating Margin
-139.1%
Net Margin
-181.1%
FCF Margin
—
ROE
—
ROCE
46.1%
ROA
-1721.5%
Effective Tax Rate
—
Métricas TTM
Revenue TTM
$123,627
Gross Profit TTM
$97,394
Operating Income TTM
−$398,820
Net Income TTM
−$515,288
FCF TTM
—
EPS TTM
-0
Quarters Used
4
TTM Period
2025-05-31 → 2026-02-28
Solidez del Balance
Net Debt
$286,187
Net Debt / EBITDA
—
Debt / Equity
-0.25
Current Ratio
0.03
Interest Coverage
—
Working Capital
−$916,878
Book Value / Share
-0
Net Debt / Share
0
Crecimiento (YoY)
Revenue YoY
+21.8%
Net Income YoY
+15.7%
FCF YoY
—
EPS Diluted YoY
+16.7%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
—
CapEx % Revenue
—
Rev / Employee
151,511
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaCBIHMediana SectorΔ
Gross Margin86.8%57.0%+29.7%
Operating Margin-139.1%-38.6%-100.4%
Net Margin-181.1%-33.6%-147.6%
FCF Margin—-13.9%—
ROE—-40.4%—
ROA-1721.5%-32.0%-1689.5%
Current Ratio0.032.84-2.81
Debt / Equity-0.250.28-0.53
Scoring Fundamental
Piotroski F-Score
4/ 9Débil
✗F1ROA positivo (rentabilidad activos)
✗F2Flujo caja operativo positivo
✗F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✓F6Liquidez mejora (current ratio)
✗F7Sin dilución accionarial
✓F8Margen bruto mejora
✓F9Rotación activos mejora
Altman Z-ScoreZona de Riesgo
-325.80
x1_working_capital-28.760
x2_retained_earnings-184.533
x3_ebit-13.217
x4_market_equity1.945
x5_sales9.505
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
2/ 8Débil
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✗DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✓ROCERetorno sobre capital empleado > 10%
✗DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✗Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos